首页 > 组织芯片 > 子宫颈 > FDU1001
tissue microarray-FDU1001
  • 点数:
    100
    例数:
    100
    点样直径(mm):
    1
    厚度(µm):
    5
    行数:
    9
    列数:
    11
    组织阵列类型:
    FFPE
    种属:
    Human
FDU1001
加入收藏

描述: 宫颈癌组织芯片,所有样本均为化疗前组织,带生存期信息,附病理分级、TNM和临床分期,100例/100点

详情: 宫颈癌组织微阵列芯片,所有样本均为化疗前组织,带生存期信息,包含鳞状细胞癌100例,一例一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Cervix
  • Malignant(IB1)
  • Malignant(IB2)
  • Malignant(IIA1)
  • Malignant(IIA2)
  • Malignant(IA2)
  • Malignant(IA1)
  • Malignant(1B2)
  • Malignant(IIIA)
  • Malignant(IIIB)
组织芯片
FDU1001
1
2
3
4
5
6
7
8
9
10
11
A
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
B
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
C
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
D
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
E
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
F
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
G
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
H
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
I
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
Cer
FDU1001
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 39 F Cervix Squamous cell carcinoma III T1b1N0M0 IB1 Malignant
A2
2 63 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
A3
3 44 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
A4
4 55 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
A5
5 52 F Cervix Squamous cell carcinoma III T2a2N0M0 IIA2 Malignant
A6
6 36 F Cervix Squamous cell carcinoma II-III T1b2N0M0 Ib2 Malignant
A7
7 51 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
A8
8 78 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
A9
9 46 F Cervix Squamous cell carcinoma III T2a2N0M0 IIA2 Malignant
A10
10 40 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
A11
11 35 F Cervix Squamous cell carcinoma III T1a2N0M0 IA2 Malignant
B1
12 42 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
B2
13 53 F Cervix Squamous cell carcinoma III T1a2N0M0 IA2 Malignant
B3
14 39 F Cervix Squamous cell carcinoma III T1b1N0M0 IB1 Malignant
B4
15 58 F Cervix Squamous cell carcinoma III T1b1N0M0 IB1 Malignant
B5
16 54 F Cervix Squamous cell carcinoma III T1b1N0M0 IB1 Malignant
B6
17 47 F Cervix Squamous cell carcinoma III T2a1N0M0 IIA1 Malignant
B7
18 53 F Cervix Squamous cell carcinoma III T1b2N0M0 IB2 Malignant
B8
19 39 F Cervix Squamous cell carcinoma III T1b2N0M0 IB2 Malignant
B9
20 54 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
B10
21 42 F Cervix Squamous cell carcinoma III T1b1N0M0 IB1 Malignant
B11
22 58 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
C1
23 38 F Cervix Squamous cell carcinoma II T1b2N0M0 IB2 Malignant
C2
24 54 F Cervix Squamous cell carcinoma II-III T1a2N0M0 IA2 Malignant
C3
25 57 F Cervix Squamous cell carcinoma II T1b1N0M0 IB1 Malignant
C4
26 64 F Cervix Squamous cell carcinoma II T1a1N0M0 IA1 Malignant
C5
27 24 F Cervix Squamous cell carcinoma II T1a2N0M0 IA2 Malignant
C6
28 42 F Cervix Squamous cell carcinoma II T1b1N0M0 IB1 Malignant
C7
29 45 F Cervix Squamous cell carcinoma II T1a2N0M0 IA2 Malignant
C8
30 41 F Cervix Squamous cell carcinoma II T1b1N1M0 IIIB Malignant
C9
31 34 F Cervix Squamous cell carcinoma II T1b1N0M0 IB1 Malignant
C10
32 71 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
C11
33 49 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
D1
34 57 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
D2
35 59 F Cervix Squamous cell carcinoma II-III T1b1N1M0 IIIB Malignant
D3
36 42 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
D4
37 52 F Cervix Squamous cell carcinoma II T1b1N0M0 IB1 Malignant
D5
38 41 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
D6
39 47 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
D7
40 49 F Cervix Squamous cell carcinoma II T3aN0M0 IIIA Malignant
D8
41 47 F Cervix Squamous cell carcinoma II T1a2N0M0 IA2 Malignant
D9
42 52 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
D10
43 46 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
D11
44 26 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
E1
45 35 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
E2
46 48 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
E3
47 48 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
E4
48 47 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
E5
49 63 F Cervix Squamous cell carcinoma II T2a2N0M0 IIA2 Malignant
E6
50 53 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
E7
51 34 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
E8
52 42 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
E9
53 36 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
E10
54 49 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
E11
55 50 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
F1
56 45 F Cervix Squamous cell carcinoma II-III T1b2N0M0 1B2 Malignant
F2
57 48 F Cervix Squamous cell carcinoma III T2a2N0M0 IIA2 Malignant
F3
58 52 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
F4
59 39 F Cervix Squamous cell carcinoma II T1b2N0M0 IB2 Malignant
F5
60 42 F Cervix Squamous cell carcinoma II-III T1a2N0M0 IA2 Malignant
F6
61 46 F Cervix Squamous cell carcinoma II T2a2N0M0 IIA2 Malignant
F7
62 28 F Cervix Squamous cell carcinoma II-III T1a2N0M0 IA2 Malignant
F8
63 42 F Cervix Squamous cell carcinoma II T1b2N0M0 IB2 Malignant
F9
64 52 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
F10
65 50 F Cervix Squamous cell carcinoma II T2a2N0M0 IIA2 Malignant
F11
66 52 F Cervix Squamous cell carcinoma II-III T1a2N0M0 IA2 Malignant
G1
67 44 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
G2
68 58 F Cervix Squamous cell carcinoma II-III T1a2N0M0 IA2 Malignant
G3
69 37 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
G4
70 58 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
G5
71 45 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
G6
72 69 F Cervix Squamous cell carcinoma II T1b1N0M0 IB1 Malignant
G7
73 58 F Cervix Squamous cell carcinoma II T2a1N0M0 IIA1 Malignant
G8
74 35 F Cervix Squamous cell carcinoma II T1b1N0M0 IB1 Malignant
G9
75 46 F Cervix Squamous cell carcinoma II T1a2N0M0 IA2 Malignant
G10
76 60 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
G11
77 50 F Cervix Squamous cell carcinoma with necrosis II-III T1b1N0M0 IB1 Malignant
H1
78 64 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
H2
79 53 F Cervix Squamous cell carcinoma II-III T1bN0M0 IB1 Malignant
H3
80 34 F Cervix Squamous cell carcinoma II T1b2N0M0 IB2 Malignant
H4
81 34 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
H5
82 62 F Cervix Squamous cell carcinoma II-III T1a2N0M0 IA2 Malignant
H6
83 56 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
H7
84 50 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
H8
85 53 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
H9
86 60 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
H10
87 40 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
H11
88 52 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
I1
89 27 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
I2
90 37 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
I3
91 51 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
I4
92 48 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
I5
93 65 F Cervix Squamous cell carcinoma II-III T1b1N0M0 IB1 Malignant
I6
94 41 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
I7
95 39 F Cervix Squamous cell carcinoma II-III T1b2N0M0 IB2 Malignant
I8
96 62 F Cervix Squamous cell carcinoma II-III T2a1N0M0 IIA1 Malignant
I9
97 64 F Cervix Squamous cell carcinoma II-III T2a2N0M0 IIA2 Malignant
I10
98 55 F Cervix Squamous cell carcinoma II T1b2N0M0 IB2 Malignant
I11
99 46 F Cervix Squamous cell carcinoma II T1b2N0M0 IB2 Malignant
J1
100 48 F Cervix Squamous cell carcinoma II T2a1N0M0 IIA1 Malignant
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们
0.144835s